1: Describe effectiveness and adverse outcomes associated with intradetrusor onabotulinumtoxinA in women with refractory OAB in the ROSETTA trial

 2: Describe target population and evaluation of microscopic hematuria in women

3: Describe 5-year outcomes of non-mesh augmented apical suspensions of the vagina


Session date: 
05/05/2017 - 8:15am to 9:15am CDT
UCMC L-168 / L-272
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Halina Zyczynski, MD